BN Stock Analysis: Brookfield | NYSE
Asset Management | NYSE, USA | Market Cap: 95.754m USD | 12M Return: 1.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 179M
EPS Trend: 47.3%
Rev. Trend: -92.8%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Brookfield Corporation (BN) is a global multi-asset alternative manager that invests across real estate, credit, renewable power and transition, infrastructure, venture capital, and private equity. The firm manages both public and private investment products and services for institutional and retail clients, deploying its own balance sheet capital alongside third-party investor capital.
Within private equity and venture capital, Brookfield pursues a wide range of strategies including acquisitions, control and distressed buyouts, corporate carve-outs, recapitalizations, and various forms of debt and mezzanine financing. It targets companies that typically own or operate underlying real assets across sectors such as industrials, building materials, metals and mining, oil and gas, paper and packaging, manufacturing, homebuilding, and forest products, with additional exposure to business services, healthcare, and residential and infrastructure services.
As a large-cap alternative asset manager classified under the Financials sector (Asset Management & Custody Banks), Brookfield earns revenue primarily through management fees on assets under management plus performance-based incentive fees (such as carried interest) common to the alternative asset management model. It invests globally with a focus on North America, Europe, Australia, the Middle East and North Africa, and Asia-Pacific.
- Fee-bearing capital crosses record milestone lifting fee-related earnings
- Renewable power cash yield expands on transition asset acquisitions
- Insurance capital inflows accelerate permanent capital base growth
| Net Income: 1.33b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -1.14 > 1.0 |
| NWC/Revenue: 32.28% < 20% (prev 36.50%; Δ -4.22% < -1%) |
| CFO/TA 0.02 > 3% & CFO 9.51b > Net Income 1.33b |
| Net Debt (261b) to EBITDA (33.7b): 7.77 < 3 |
| Current Ratio: 1.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.37b) vs 12m ago 2.24% < -2% |
| Gross Margin: 35.28% > 18% (prev 26.11%; Δ 9.17% > 0.5%) |
| Asset Turnover: 15.12% > 50% (prev 16.49%; Δ -1.37% > 0%) |
| Interest Coverage Ratio: 1.34 > 6 (EBIT TTM 23.2b / Interest Expense TTM 17.2b) |
| A: 0.05 (Total Current Assets 59.1b - Total Current Liabilities 34.4b) / Total Assets 521b |
| B: 0.03 (Retained Earnings 16.2b / Total Assets 521b) |
| C: 0.05 (EBIT TTM 23.2b / Avg Total Assets 506b) |
| D: 0.13 (Book Value of Equity 46.9b / Total Liabilities 355b) |
| Altman-Z'' = 0.86 = B |
| DSRI: 1.53 (Receivables 44.0b/30.5b, Revenue 76.6b/81.0b) |
| GMI: 0.74 (GM 26.11% / 35.28%) |
| AQI: 1.01 (AQ_t 0.56 / AQ_t-1 0.56) |
| SGI: 0.94 (Revenue 76.6b / 81.0b) |
| TATA: -0.02 (NI 1.33b - CFO 9.51b) / TA 521b) |
| Beneish M = -2.86 (Cap -4..+1) = A |
As of July 05, 2026, the stock is trading at USD 43.43 with a total of 3,711,451 shares traded. Over the past week, the price has changed by +1.00%, over one month by -0.87%, over three months by +6.72% and over the past year by +1.92%.
Current recommended Stop Loss: 41.80 (which is 3.8% or 1.5 ATR below the current price).
Brookfield has received a consensus analysts rating of 4.18. Therefore, it is recommended to buy BN.
- StrongBuy: 5
- Buy: 5
- Hold: 0
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 54.4 | 25.3% |
P/E Trailing = 84.0588
P/E Forward = 11.8906
P/S = 1.2103
P/B = 2.4611
P/EG = 1.2722
Revenue TTM = 76.6b USD
EBIT TTM = 23.2b USD
EBITDA TTM = 33.7b USD
Long Term Debt = 229b USD (from longTermDebt, last quarter)
Short Term Debt = 34.4b USD (from shortTermDebt, last quarter)
Debt = 277b USD (from shortLongTermDebtTotal, last quarter) + Leases 8.22b
Net Debt = 261b USD (calculated: Debt 277b - CCE 15.1b)
Enterprise Value = 357b USD (95.8b + Debt 277b - CCE 15.1b)
Interest Coverage Ratio = 1.34 (Ebit TTM 23.2b / Interest Expense TTM 17.2b)
EV/FCF = -43.21x (Enterprise Value 357b / FCF TTM -8.27b)
FCF Yield = -2.31% (FCF TTM -8.27b / Enterprise Value 357b)
FCF Margin = -10.80% (FCF TTM -8.27b / Revenue TTM 76.6b)
Net Margin = 1.74% (Net Income TTM 1.33b / Revenue TTM 76.6b)
Gross Margin = 35.28% ((Revenue TTM 76.6b - Cost of Revenue TTM 49.6b) / Revenue TTM)
Gross Margin QoQ = 24.10% (prev 42.05%)
Tobins Q-Ratio = 0.69 (Enterprise Value 357b / Total Assets 521b)
Interest Expense / Debt = 6.23% (Interest Expense 17.2b / Debt 277b)
Taxrate = 22.04% (1.14b / 5.19b)
NOPAT = 18.1b (EBIT 23.2b * (1 - 22.04%))
Current Ratio = 1.72 (Total Current Assets 59.1b / Total Current Liabilities 34.4b)
Debt / Equity = 5.89 (Debt 277b / totalStockholderEquity, last quarter 46.9b)
Debt / EBITDA = 7.77 (Net Debt 261b / EBITDA 33.7b)
Debt / FCF = -31.63 (negative FCF - burning cash) (Net Debt 261b / FCF TTM -8.27b)
Total Stockholder Equity = 47.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.26% (Net Income 1.33b / Total Assets 521b)
RoE = 2.84% (Net Income TTM 1.33b / Total Stockholder Equity 47.0b)
RoCE = 8.38% (EBIT 23.2b / Capital Employed (Equity 47.0b + L.T.Debt 229b))
RoIC = 3.49% (NOPAT 18.1b / Invested Capital 517b)
WACC = 6.52% (E(95.8b)/V(372b) * Re(11.34%) + D(277b)/V(372b) * Rd(6.23%) * (1-Tc(0.22)))
Discount Rate = 11.34% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 25.01 | Cagr: -0.08%
[DCF] Fair Price = unknown (Cash Flow -8.27b)
EPS Correlation: 47.28 | EPS CAGR: 72.46% | SUE: N/A | # QB: 0
Revenue Correlation: -92.82 | Revenue CAGR: -10.37% | SUE: 0.68 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-09-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=2.87 | Chg30d=N/A | Revisions=+0% | GrowthEPS=+0.0% | GrowthRev=-9.8%
EPS next Year (2027-12-31): EPS=3.51 | Chg30d=N/A | Revisions=+0% | GrowthEPS=+22.3% | GrowthRev=+31.3%